Fast, accurate diagnosis of multiple sclerosis (MS) can be life-changing for patients, and new updates to the existing criteria are aiming to make that possible, ensuring that those living with the condition get the treatment they need when it matters most. Building on decades of research and clinical experience, the McDonald diagnostic criteria have served as a cornerstone in diagnosing MS, evolving over the years to keep up with the advancements occurring in the field. First established in 20011 and revised most recently in 20172, the criteria aim to balance sensitivity and specificity in identifying MS.
Since 2021, a panel of experts has been refining the guidelines to integrate cutting-edge insights into the disease’s biological mechanisms. This latest update…